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A toxin isolated from marine sponge, mycalolide-B, inhibited smooth muscle contractions without changing cytosolic Ca*’ levels. It also inhibited 
Ca*‘-induced contraction in permeabilized smooth muscles. In native actomyosin prepared from chicken gizzard, mycalolide-B inhibited superpre- 
cipitation and MgZ’-ATPase activity stimulated by Cal’ without changing myosin light chain phosphorylation. In the permeabilized muscle and 
native actomyosin preparation thiophosphorylated with ATPyS, mycalolide-B inhibited ATP-induced contraction and Mg*‘-ATPase activity, 
respectively, in the absence of Ca’+. Mycalolide-B also inhibited Mg*‘-ATPase activity of skeletal muscle native actomyosin. Mycalolide-B had 
no effect on calmodulin-stimulated (Ca”-Mg”)-ATPase activity of erythrocyte membranes. These results suggest hat mycalolide-B selectively 
inhibits actin-myosin interaction. 
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1. INTRODUCTION 
Recently, three novel cytotoxic compounds, mycalol- 
ide-A, B and C were isolated from a marine sponge of 
the genus Mycale in the Bay of Gokasho, Kii Peninsula, 
Japan [l]. Mycalolide-B belongs to macrolide antibiot- 
ics and consists of tris-oxazole with chemical structure 
of C52H74N40,7 (M.W. = 1052) (Fig. 1) with strong cy- 
totoxic activity (IC,, : 10-50 nM for growth of L1210 
murine leukemia cells) [2]. In this study, we investigated 
the effect of mycalolide-B on contraction and biochem- 
ical parameters in smooth, skeletal and cardiac muscles, 
and found that this toxin selectively inhibits actin- 
myosin interaction. 
2. MATERIALS AND METHODS 
2.1. Muscle preparation and solutions 
Thoracic aorta was isolated from male Wistar rats (200-250 g) and 
mesenteric artery and psoas muscle and heart were isolated from male 
New Zealand White rabbits (2-3 kg). Papillary muscle was removed 
from the heart to make permeabilized muscle preparations. Endothe- 
lium was removed from vascular muscles. Gizzard isolated from 
chicken (1.5-2 kg) and rabbit psoas muscle were used to make native 
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actomyosin preparations. The physiological salt solution (PSS) con- 
tained (in mM): NaCl 136.9; KC1 5.4; CaCl, 1.5; MgCl, 1 .O; NaHCO, 
23.8; glucose 5.5 and enthylenediamine t traacetic acid 0.01. A high 
K’ solution was made by substituting equimolar KC1 for NaCl. The 
Ca*‘-free solution was made by removing CaCl, and adding 0.5 mM 
EGTA. 
2.2. [Ca”], and tension measurement 
The cytosolic Ca’+ level ([Ca2’li) was measured simultaneously with 
muscle tension [3,4] using a fluorescent Ca*’ indicator, fura- [5]. Rat 
aorta was loaded with acetoxymethyl ester of fura- which was dis- 
solved in PSS for 4 h at room temperature. The muscle strip was 
illuminated alternately (48 Hz) at the excitation wavelengths of 340 nm 
and 380 nm and the amount of 500 nm fluorescence induced by 340 
nm excitation (F,,,) and that induced by 380 nm excitation (&,,) was 
measured using a fluorimeter (CAF-100, Japan Spectroscopic, Tokyo, 
Japan). The ratio of FjdO to FASO (R,,,,,,) was used as an indicator of 
[Ca’+],. Muscle tension was recorded isometrically with a force dis- 
placement ransducer. 
2.3 Permeabilized musrle 
Permeabilized muscle preparations were obtained according to the 
method described by Sparrow et al. [6] and Sugi et al. [7]. A thin bundle 
(0.3 mm in width and 3 mm in length) of mesenteric artery, papillary 
muscle or skeletal muscle were prepared in PSS and permeabilized 
using Triton X-100 or glycerol. The relaxing solution for permeabil- 
ized smooth muscle contained: 20 mM imidazole (pH 7.4 at 4°C); 50 
mM KC]; 4 mM MgCl,; 3 mM ATP; 1 mM NaN,; 0.2pM calmodulin, 
1 mM creatine phosphate; 10 U/ml creatine phosphokinase and 2 mM 
EGTA at pH 6.8 and 25°C. The free Ca’+ concentration was changed 
by adding an appropriate amount of CaCl, (Ca*‘-EGTA buffer). In 
permeabilized cardiac and skeletal muscles, creatine phosphate, 
creatine phosphokinase and calmodulin were removed from the relax- 
ing solution. The apparent binding constant of EGTA for Ca” was 
considered to be 10m6 M at pH 6.8 [8]. Muscle tension was measured 
isometrically under the resting tension of approximately 50 mg. 
In some experiments, MLC was thiophosphorylated by adding 1 
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Fig. 1. Chemical structure of mycalolide-B isolated from marine 
sponge of the genus Mycale. 
PM Ca2’ and 1 mM ATPyS in the absence of ATP for 10 min 191. 
Sequential addition of ATP caused a sustained contraction in the 
absence of Ca2’ [9,10]. 
2.4. Native actomyosin preparation 
Native actomyosin was prepared from chicken gizzard or rabbit 
skeletal muscle according to the method described by Ozaki et al. 
IlO, I]. Protein concentration was determined by the Lowry method 
[12] using bovine serum albumin as a standard. 
2.5. Superprecipitation 
Superprecipitation of native actomyosin was measured by modify- 
ing the method reported by Ebashi [13]. The reaction buffer solution 
contained 1 mg/ml native actomyosin, 50 mM KCl, 4 mM MgCl,, 2 
mM EGTA and 20 mM Tris-maleate (pH 6.8 at 4°C) and the reaction 
was started by adding 1 mM ATP. Superprecipitation was measured 
by the optical density of actomyosin suspension at 690 nm using a 
spectrophotometer (UVDEC-460, Japan Spectroscopic) at 25°C stir- 
ring continuously. 
2.6. MC-ATPase activity 
Mg”-ATPase activity of native actomyosin prepared from chicken 
gizzard or skeletal muscle were measured by the method described 
previously [IO,1 11. The reaction buffer was of the same content as that 
of superprecipitation. The reaction was started by 1 mM ATP and 
stopped by 5% TCA. Liberated inorganic phosphate was determined 
by the method of Martin and Doty [14]. 
Thiophosphorylated native actomyosin preparations were prepared 
by the following protocol. Native actomyosin was treated with reac- 
tion buffer containing 10 ,uM Ca”’ and 1 mM ATPyS in the absence 
of ATP and EGTA for 15 min. Sequential addition of 2 mM EGTA 
was carried out for chelating free Ca2’. The reaction was started by 
addition of 1 mM ATP in the absence of Ca”. 
2.1. Myosin light chain phosphorylation 
Phosphorylation of the 20 kDa myosin light chain (MLC) was 
carried out using the same reaction mixture as that for superprecipita- 
tion. The reaction was started by adding 1 mM ATP and stopped by 
adding urea to 8 M. The extent of phosphorylated MLC after 1 min 
was measured by microdensitometry after urea-PAGE [15]. 
2.8. (Cd’-MC)-ATPase activity of erythrocyte membranes 
Erythrocyte membranes were prepared from rabbit erythrocytes 
[IO,1 1,161. The reaction buffer solution contained 100 mM NaCI, 10 
mM KCl, 3 mM MgCI,, 20 mM Tris-maleate (pH 6.8 at 25”C), 0.1 
mM ouabain, 30 nM calmodulin, 1 mg protein/ml erythrocyte mem- 
branes and Ca2’-EGTA buffer (pCa 5). The reaction was started by 
adding 1 mM ATP and stopped by adding 5% TCA. Liberated inor- 
ganic phosphate after 30 min was measured by the Martin-Doty 
method. 
2.9. Chemicals 
Drugs used were imidazole (Wako Pure Chemical, Tokyo, Japan), 
Tris-HCI, DFP, creatine phosphate, phosphocreatine kinase, ATP, 
ATPyS, Triton X-100 (Sigma, St. Louis, MO), DTE, DTT, cremo- 
phor EL (Nacalai Tesque, Tokyo, Japan), and fura-2/AM, EDTA, 
EGTA (Dojindo Laboratories, Kumamoto, Japan). 
3. RESULTS 
In fura-2-loaded rat aorta, high K’ (72.4 mM) in- 
creased [Ca2+]i and muscle tension. Mycalolide-B (10 
FM), added during a high K’-induced sustained con- 
traction, decreased force without changing [Ca2+]i (Fig. 
2A). Mycalolide-B (10 ,DM) completely inhibited the 
contractions induced by high K’ or norepinephrine 
(NE; 0.01-l FM) with a similar time course (time to 
50% relaxation; 8-10 min). Concentrations to induce 
50% inhibition (IC,,) of contractions induced by high 
K’ or NE (0.01, 0.1 and 1 PM) were 40, 110, 210 and 
220 nM, respectively (n = 4 each). Caffeine (20 mM) 
caused transient increases in [Ca2’li and force in the 
Ca2+-free solution (with 0.5 mM EGTA). Mycalolide-B 
(30 PM) inhibited the caffeine-induced contraction 
without affecting the change in [Ca’+], (Fig. 2B). 
In permeabilized rabbit mesenteric artery, Ca2’ (1 
PM) induced sustained contraction. Mycalolide-B (10 
PM) completely inhibited this contraction (Fig. 3A). 
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Fig. 2. Effect of mycalolide-B on [Ca”], and contraction in fura-2- 
loaded rat aorta. In panel A, mycalolide-B (10 PM) was applied 5 min 
after the addition of high K’ (72.7 mM). In panel B, high K’ was 
added followed by the addition of caffeine (20 mM) which induced 
transient increases in [Ca”], and force in Ca’+-free solution (0.5 mM 
EGTA). After observing the control responses, muscle strip was 
treated with mycalolide-B (30 PM) for 30 min and high K’ and caf- 
feine were added. R340/380; an indicator of [Caz’li. 100% represents 
the steady level of high K’-induced increase in [Ca”],. 
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Fig. 3. Inhibitory effect of mycalolide-B on contractions in permeabil- 
ized rabbit mesenteric artery. In panel A, 10 PM mycalolide-B was 
added after the contraction induced by 1 ,uM Ca” reached a plateau. 
Panel B shows the concentration-response relationship for the inhib- 
itory effects of mycalolide-B on contractions induced by 1 PM (0) or 
3 ,uM (0) Ca*‘. Each point represents the mean values f S.E.M. of 46 
experiments measured 60 min after the addition of mycalolide-B. 
Panel C shows the effects of mycalolide-B (10 PM) on Ca*‘-independ- 
ent contraction obtained in thiophosphorylated muscle. Dotted line 
represents contraction in the absence of mycalolide-B. 
Concentration-response curves for the inhibitory ef- 
fects of mycalolide-B on the contractions induced by 
Ca” (1 and 3 PM) are shown in Fig. 3B. The inhibitory 
effect of mycalolide-B was not modified by changing the 
Ca2’ concentration. Mycalolide-B (10 PM) also com- 
pletely inhibited the contraction of permeabilized car- 
diac and skeletal muscles induced by 3 ,uM Ca” (n = 4). 
Mycalolide-B (10 ,uM) completely inhibited the Ca2’- 
independent contraction in the thiophosphorylated per- 
meabilized smooth muscle (Fig. 3C). 
In the presence of 3 or 10 ,uM Ca2+, ATP (1 mM) 
increased the turbidity of the native actomyosin suspen- 
sion (superprecipitation) prepared from chicken giz- 
zard. Mycalolide-B (3-100 ,uM) inhibited the superpre- 
cipitation in a concentration-dependent manner (Fig. 
4A; IC,,, 9.6,~M in the presence of 3 ,uM Ca2’, and 8.2 
PM in the presence of 10 ,Ka2’). However, mycalolide- 
B (10 PM) had no effect on the MLC phosphorylation 
at any Ca2’ level (Fig. 4B). Fig. 4C shows the effect of 
mycalolide-B on Mg2’-ATPase activity of phosphor- 
ylated or thiophosphorylated native actomyosin. Mg2+- 
ATPase activity increased 1.4 times in the presence of 
3 PM Ca2’ and 1 mM ATP. In the thiophosphorylated 
native actomyosin, 1 mM ATP increased Mg”-ATPase 
activity to 1.6 times in the absence of Ca*’ (with 2 mM 
EGTA). Mycalolide-B inhibited the increases in Mg2+- 
ATPase activity in a concentration-dependent manner. 
The ICso values in phosphorylated and thio- 
phosphorylated Mg2’-ATPase activity were 3.9 ,uM and 
4.7 ,uM, respectively. In skeletal muscle native acto- 
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Fig. 4. Effect of mycalolide-B on superprecipitation (A), MLC phos- 
phorylation (B) and Mg”-ATPase activity (C) of native actomyosin 
prepared from chicken gizzard. Preparations were treated with 
mycalolide-B for 120 min. Panel A: C, 3 PM Ca2+; l , 10 PM Ca*‘. 
Turbidity of native actomyosin was continuously monitored and the 
maximum increase in the turbidity in the presence of 3 or 10pM Ca” 
was normalized and plotted. Panel B: 0, control; l , mycalolide-B 10 
PM: Panel C: o, Mg’-ATPase activity stimulated by 3 ,uM Ca*+ and 
1 mM ATP; l , M$‘-ATPase activity stimulated by 1 mM ATP with- 
out Ca” in the thiophosphorylated native actomyosin. Hydrolyzed 
inorganic phosphate (nmole P,/mg protein) was measured at 30 min.. 
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myosin, mycalolide-B (10 PM) also completely sup- 
pressed the Mg2’-ATPase activity stimulated by 1 or 
100 ,uM Ca2’ (n = 4 each). 
Mycalolide-B (3-30 PM) did not change the (Ca”- 
Mg2’)-ATPase activity of erythrocyte membranes when 
assayed in the presence of 3 ,uM Ca” and 30 nM calm- 
odulin (Control, 1.83 + 0.09; 3 FM Ca’+, 17.1 & 0.14; 3 
PM Ca2’ + 3 ,uM mycalolide-B, 17.0 2 0.34; 3 PM Ca2’ 
+ 10 PM mycalolide-B, 16.8 f 0.23 nmol PJmg protein/ 
min). 
4. DISCUSSION 
In vascular smooth muscle, it has been shown that 
high-K’ depolarization and caffeine induce contrac- 
tions by opening Ca2’ channels [17,181 and by releasing 
Ca2’ from the sarcoplasmic reticulum [19,20], respec- 
tively. Mycalolide-B inhibited these contractions with a 
similar time course at a similar concentration range. 
However, mycalolide-B did not change the stimulated 
[Ca2’]i. These results suggest hat the relaxant effect of 
mycalolide-B is not due to change in Ca2’ movements. 
In permeabilized smooth muscle, mycalolide-B inhib- 
ited the Ca2’-induced contractions. Mycalolide-B also 
inhibited the superprecipitation and Mg2’-ATPase ac- 
tivity of native actomyosin prepared from chicken giz- 
zards. These results suggests that mycalolide-B directly 
inhibits contractile elements. 
Contraction of smooth muscle is considered to be 
primarily regulated by the Ca”/calmodulin-dependent 
MLC phosphorylation [21,22]. The inhibitory effect of 
mycalolide-B, however, was not followed by the inhibi- 
tion of MLC phosphorylation at any Ca2’ concentra- 
tions. Furthermore, mycalolide-B did not inhibit the 
calmodulin activity as measured by (Ca2+-Mg2+)-ATP- 
ase of erythrocytes membrane. All of these observations 
suggest hat mycalolide-B inhibits smooth muscle con- 
tractile element at the step(s) after the MLC phospho- 
rylation. 
In permeabilized smooth muscle pretreated with 
ATPyS and Ca2’, ATP evokes sustained contraction in 
the absence of Ca2’ [9,10]. This contraction is due to the 
direct interaction between actin and thiophosphor- 
ylated myosin which is not dephosphorylated by protein 
phosphatases [9]. Mycalolide-B completely inhibited 
this contraction. Mycalolide-B also inhibited the Mg2+- 
ATPase activity of thiophosphorylated native acto- 
myosin prepared from chicken gizzards. These results 
suggest hat mycalolide-B directly inhibits actin-myosin 
interaction. 
We further examined whether mycalolide-B inhibits 
contractile elements of skeletal and cardiac muscles. 
Mycalolide-B completely inhibited both the Ca2’-in- 
duced contraction in permeabilized skeletal muscle and 
Mg2’-ATPase activity in native actomyosin prepared 
from skeletal muscle. Mycolalide-B also inhibited Ca2’- 
induced contractions in permeabilized cardiac muscle. 
These results strongly suggest hat mycalolide-B inhib- 
its actomyosin not only in smooth muscle but also in 
skeletal and cardiac muscles. Further studies are now 
in progress to clarify the molecular mechanism of 
mycalolide-B on actin and myosin. 
Acknowledgements: This study was supported by a Grant-in-aid for 
Scientific Research from the Ministry of Education, Science and Cul- 
ture of Japan. 
REFERENCES 
111 
121 
[31 
[41 
151 
bl 
[71 
PI 
191 
VOI 
[ill 
1121 
[I31 
1141 
t151 
[I61 
u71 
WI 
u91 
[201 
1211 
P21 
Fusetani, N., Yasumuro, K., Matsunaga, S. and Hashimoto, K. 
(1989) Tetrahedron Lett. 30, 2809-2812. 
Fusetani, N. (1990) New J. Chem. 14, 721-728. 
Ozaki, H., Sato, K. and Karaki, H. (1987) Japan. J. Pharmacol. 
45,429433. 
Sato, K., Ozaki, H. and Karaki, H. (1988) J. Pharmacol. Exp. 
Ther. 246,294300. 
Grinkiewicz, G., Poenie, M. and Tsien, R.Y. (1985) J. Biol. 
Chem. 260, 3440-3450. 
Sparrow, M.P., Mrwa, U., Hofmann, F. and Riiegg, J.C. (1981) 
FEBS Lett. 125, 141-145. 
Sugi, H., Kobayashi, T., Gross, T., Noguchi, K., Karr, T. and 
Harrington, W.F. (1992) Proc. Nat]. Acad. Sci. USA 89, 6134 
6137. 
Harafuji, H. and Ogawa, Y. (1980) J. Biochem. (Tokyo) 87, 
1305-1312. 
Cassidy, P.S., Hoar, P.E. and Kerrick, W.G.L. (1979) J. Biol. 
Chem. 254, 11148-l 1153. 
Ozaki, H., Kojima, T., Moriyama, T., Karaki, H., Urakawa, N., 
Kohama, K. and Nonomura, Y. (1987) J. Pharmacol. Exp. Ther. 
243, 370-377. 
Ozaki, H., Ishihara, H., Kohama, K., Nonomura, Y., Shibata, 
S. and Karaki, H. (1987) J. Pharmacol. Exp. Ther. 243, 1167- 
1173. 
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. 
(1951) J. Biol. Chem. 193, 265-275. 
Ebashi, S. (1961) J. Biochem. (Tokyo) 50, 236244. 
Martin, J.B. and Doty, D.M. (1949) Anal. Chem. 21, 965-967. 
Pires, E., Perry, S.V. and Thomas, M.A.W. (1974) FEBS Lett. 41, 
2922296. 
Gopinath, R.M. and Vincenzi, F.F. (1977) Biochem. Biophys. 
Res. Commun. 77, 1203-1209. 
Bolton, T.B. (1979) Physiol. Rev. 59, 606718. 
Karaki, H. and Weiss, G.B. (1984) Gastroenterology 87, 960- 
970. 
Endo, M. (1977) Physiol. Rev. 57, 71-108. 
Karaki, H. and Weiss, G.B. (1988) Life Sci. 42, 111-122. 
Kamm, K.E. and Stull, J.T. (1985) Annu. Rev. Pharmacol. Tox- 
icol. 25, 5933620. 
Hartshorne, D.J. (1987) in: Physiology of the Gastrointestinal 
Tract (Johnson, L.R. Ed.) 2nd Edn. pp. 423482, Raven Press, 
New York. 
154 
